Alejandro Recio‐Boiles

Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3

Petros Grivas, Damien Pouessel, Chandler H. Park et al. · Journal of Clinical Oncology · 2024 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT)

Alejandro Recio‐Boiles, Jose Nahun Galeas, Bernard Goldwasser et al. · Supportive Care in Cancer · 2018 · 50 citations

Medicine, Oncology, Radiology +16

Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma

Jun Zhao, Jody V. Vykoukal, Mohamed E. Abdelsalam et al. · Nanotechnology · 2014 · 47 citations

Pharmacy, Biotechnology, Pharmaceutics +17

TROPHY-U-01 Cohort 3: Sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) who progressed after platinum (PLT)-based regimens.

Petros Grivas, Damien Pouessel, Chandler H. Park et al. · Journal of Clinical Oncology · 2022 · 36 citations

Pharmacy, Oncology, Pharmacotherapy +17

JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells

Alejandro Recio‐Boiles, Matthias Ilmer, Patrea R. Rhea et al. · Oncotarget · 2016 · 28 citations · Full text

Medicine, Cell Biology, Oncology +17